Genitourinary Radiology: Page 84

Amersham, Galil Medical to merge therapy units
By AuntMinnie.com staff writers
With an eye on building a global presence in prostate cancer treatment, Amersham and cryotherapy developer Galil Medical of Yokneam, Israel, have agreed to merge Amersham Health's brachytherapy unit with Galil's urology operations.
April 22, 2003
Cytogen, DraxImage terminate brachytherapy agreement
By AuntMinnie.com staff writers
Radiopharmaceutical firm DraxImage of Kirkland, Quebec, and biopharmaceutical firm Cytogen of Princeton, NJ, have terminated agreements for DraxImage’s BrachySeed I-125 and BrachySeed Pd-103 products.
April 8, 2003
PET/CT boosts confidence in rectal cancer staging, US yields high sensitivity
By Eric Barnes
Restaging rectal cancer after surgery was more accurate with PET/CT than with PET alone, according to a study presented at the 2003 European Congress of Radiology. Other studies found that ultrasound beats both MR and CT for assessing local tumor invasion, and that CT multiplanar reconstructions are better than the standard axial kind for staging.
April 2, 2003
New reports address prostate cancer staging, therapy
By Tracie L. Thompson
Dutch researchers have found 11C-choline PET imaging to be more accurate than MRI or CT in staging of lymph node involvement in prostate cancer; meanwhile, a new U.S. database analysis says that younger prostate cancer patients shouldn’t be steered away from radiation therapy merely because of their age.
March 23, 2003
HKSH performs C-11 whole-body PET/CT scans
By AuntMinnie.com staff writers
Hong Kong Sanatorium & Hospital (HKSH) has performed whole-body PET/CT scans using short half-life C-11 radiopharmaceuticals, according to Siemens Medical Solutions.
January 26, 2003
Production of palladium BrachySeed version halted
By AuntMinnie.com staff writers
Pharmaceutical firm Cytogen and radiopharmaceutical manufacturer DraxImage said that production and sales of the palladium version of their BrachySeed prostate cancer brachytherapy implants have been halted for an unspecified period of time.
January 16, 2003
E-Z-EM posts positive Q2
By AuntMinnie.com staff writers
Virtual colonoscopy and contrast developer E-Z-EM reported fiscal 2003 second-quarter sales of $32.9 million, up 8% compared with the $30.6 million posted in its 2002 fiscal second quarter.
January 14, 2003
PET/CT shows promise for peritoneal carcinomatosis
By Jonathan S. Batchelor
CHICAGO - The combination of two technologies with PET/CT fusion imaging could provide the best possible imaging study for the detection of ovarian cancer.
December 5, 2002
MR spectroscopy provides noninvasive prostate cancer staging
CHICAGO - Researchers from Memorial Sloan-Kettering Cancer Center in New York City are reporting that proton magnetic resonance spectroscopy (MRS) can accurately predict Gleason scores in prostate cancer, making it the first effective, noninvasive method for staging prostate cancer.
December 4, 2002
BioSphere gets FDA clearance for UFE microspheres
By AuntMinnie.com staff writers
Interventional device developer BioSphere Medical of Rockland, MA, has received Food and Drug Administration clearance for its uterine fibroid embolization (UFE) product, Embosphere Microsphere. The product uses microspheres to block the growth of uterine fibroids by cutting off their blood supply.
November 26, 2002
Nucletron product gets FDA 510(k) clearance
By AuntMinnie.com staff writers
Dutch radiation therapy firm Nucletron has gained U.S. Food and Drug Administration 510(k) clearance for its Spot Pro 3-D ultrasound planning system for all seed-implant techniques.
November 19, 2002
Mentor to buy ProstaSeed maker Mills
By AuntMinnie.com staff writers
Mentor of Santa Barbara, CA, has reached an agreement to acquire Mills Biopharmaceuticals of Oklahoma City, OK.
November 5, 2002
Previous Page
Page 84 of 93
Next Page